Evidence map›Paper›PMID 29581270›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2018

Kv4.2 autism and epilepsy mutation enhances inactivation of closed channels but impairs access to inactivated state after opening.

Meng-Chin A Lin, Stephen C Cannon, Diane M Papazian

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 45 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Kv4.2The Journal of neuroscience : the official journal of the Society for Neuroscience · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Design of Ultrapotent Genetically Encoded Inhibitors of Kv4.2 for Gating Neural Plasticity.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2024
    Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. ReducedFrontiers in cell and developmental biology · 2022
    Article
  17. Article
  18. Article
  19. Channelopathies in fragile X syndrome.Nature reviews. Neuroscience · 2021
    Review
  20. Variation of Two S3b Residues in KFrontiers in pharmacology · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Meng-Chin A LinDepartment of Physiology, David Geffen School of Medicine at the University of California, Los Angeles, CA 90095-1751.
Stephen C CannonDepartment of Physiology, David Geffen School of Medicine at the University of California, Los Angeles, CA 90095-1751.
Diane M PapazianDepartment of Physiology, David Geffen School of Medicine at the University of California, Los Angeles, CA 90095-1751; papazian@mednet.ucla.edu.ORCID 0000-0001-8194-5740
University of California, Los Angeles · US

Funding

Voltage-Dependent Activation in K+ ChannelsR01GM043459 · NIGMS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI PAPAZIAN, DIANE M · 1990 to 2014
$4.1M
NIGMS NIH HHS R01 GM043459
6 · The paper itself

Abstract

A de novo mutation in the

Indexed as

AnimalsAutistic DisorderEpilepsyFemaleHumansKv Channel-Interacting ProteinsMembrane PotentialsMutationOocytesPatch-Clamp TechniquesPolymorphism, GeneticRepressor ProteinsShal Potassium ChannelsTransfectionXenopus laevisKCND2 protein, humanKCNIP3 protein, humanKv Channel-Interacting ProteinsRepressor ProteinsShal Potassium ChannelsA-type currentclosed-state inactivationgain-of-function mutationK+ channel gatingsomatodendritic

Identifiers

PMID29581270
PMCPMC5899440
OpenAlexW2792751889

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.